sSmartPower ATE

 

 

s
 
SmartPower ATE Ltd

Products

Support

About Us

Contact Us

Overview

SmartPowerATE is headquartered in Limerick ,Ireland , is a leader in the design and manufacture of Recycling Energy loads as well as Burn-in and Reliability ATE Test Systems used in test applications in the Power Electronics industry.


SmartPowerate’s products include -

 

pointRecycling Energy AC/DC Electronic Loads from 100W to 200KW

most effective time to take viagrapointBurn-in/Reliability ATE Test Systems

 

 

SmartPower Products are used in for the following Burn-in , HASS and HALT testing applications

 

AC/DC Power Supply

DC/DC Converter and Rectifier

UPS and Inverter

 

 

Test systems for ESS RSS and product life cycle burn in

 

 

Whether you're already a SmartPower ATE customer or are new to SmartPower’s products  , we welcome inquiries on our products and the opportunity to help solve your power burn-in or reliability test requirements.

 

    hub sciencedirect scopus applications register login login go to scival suite username: password: remember me | not registered? Forgotten your username or password? Go to athens / institution login remote access activation home publications search my settings my alerts shopping cart help export citation purchase more options... cheap viagra online buy cheap viagra buy generic viagra cheap generic viagra viagra for sale viagra without a doctor prescription buy viagra cheap viagra online viagra without a doctor prescription buy generic viagra Email article signed up for journal alerts [remove] alert me about new articles in this journal your selection(s) could not be saved due to an internal error. Please try again. Search     all fields     author advanced search     journal/book title     volume   issue   page search tips article outline is loading... Javascript required for article outline seminars in nuclear medicine volume 37, issue 6, november 2007, pages 400–419 positron emission tomography with fluorine-18 agents other than fluorodeoxyglucose 18f-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization shankar vallabhajosula, phd , division of nuclear medicine, department of radiology and citigroup biomedical imaging center (cbic), new york presbyterian hospital and weill cornell medical college, cornell university, new york, ny. Available online 3 october 2007 how to cite or link using doi permissions & reprints view full text purchase $31. 50 clinical fdg-pet limitations of fdg-pet 18f-labeled pet radiopharmaceuticals excluding fdg 18f: ideal positron-emitting radionuclide development of pet radiopharmaceuticals: biochemical basis glucose metabolism: [18f]fdg bone metabolism: [18f]fluoride dna synthesis: 3′-deoxy-3′-[18f]fluorothymidine (flt) membrane lipid synthesis: [18f]fluorocholine (fch) and 18f-acetate amino acid (aa) transport and protein synthesis: [18f]fdopa tumor hypoxia: [18f]fluoromisonidazole (fmiso) estrogen receptor binding: [18f]fluoroestradiol (fes) radiochemistry of 18f-labeled radiopharmaceuticals fdopa synthesis flt synthesis fmiso synthesis fes synthesis fch synthesis automated synthesis modules radiation dosimetry pet radiopharmaceuticals: the role of fda pet drugs: current good manufacturing practices (cgmps) references molecular imaging is the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in a living system. At present, positron emission tomography/computed tomography (pet/ct) is one the most rapidly growing areas of medical imaging, with many applications in the clinical management of patients with cancer. Although [18f]fluorodeoxyglucose (fdg)-pet/ct imaging provides high specificity and sensitivity in several kinds of cance.